350
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine

, , , , &
Pages 394-400 | Published online: 09 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Gabriele S. Merki-Feld, Bruno Imthurn, Andreas R. Gantenbein & Peter Sandor. (2019) Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial. The European Journal of Contraception & Reproductive Health Care 24:3, pages 175-181.
Read now
G. Allais, Giulia Chiarle, Silvia Sinigaglia & Chiara Benedetto. (2018) Menstrual migraine: a review of current and developing pharmacotherapies for women. Expert Opinion on Pharmacotherapy 19:2, pages 123-136.
Read now
Gabriele S. Merki-Feld, Bruno Imthurn, Raghvendran Dubey, Peter S. Sándor & Andreas R. Gantenbein. (2017) Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives?. Journal of Obstetrics and Gynaecology 37:3, pages 338-341.
Read now
Gianni Allais, Giulia Chiarle, Fabiola Bergandi & Chiara Benedetto. (2016) The use of progestogen-only pill in migraine patients. Expert Review of Neurotherapeutics 16:1, pages 71-82.
Read now
Gabriele S. Merki-Feld, Sven Skouby, David Serfaty, Medard Lech, Johannes Bitzer, Pier Giorgio Crosignani, Angelo Cagnacci & Regine Sitruk-Ware. (2015) European Society of Contraception Statement on Contraception in Obese Women. The European Journal of Contraception & Reproductive Health Care 20:1, pages 19-28.
Read now

Articles from other publishers (20)

Mira P. Fitzek, Elisabeth Storch, Lucas H. Overeem, Pia Kull, Maria Terhart, Kristin S. Lange, Uwe Reuter & Bianca Raffaelli. (2023) Migraine and Hormonal Contraception in Gynecological Outpatient Care—Cross-Sectional Study among Practicing Gynecologists in Germany. Journal of Clinical Medicine 12:4, pages 1434.
Crossref
Rossella Nappi, Lara Tiranini, Simona Sacco, Eleonora De Matteis, Roberto De Icco & Cristina Tassorelli. (2022) Role of Estrogens in Menstrual Migraine. Cells 11:8, pages 1355.
Crossref
Gabriele S. Merki-Feld, Peter S. Sandor, Rossella E. Nappi, Heiko Pohl & Christoph Schankin. (2021) Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study. Acta Neurologica Belgica 122:2, pages 401-409.
Crossref
Joy-Fleur van der Vaart & Gabriele Susanne Merki-Feld. (2022) Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review. Women's Health 18, pages 174550572211113.
Crossref
Hannah J. Roeder & Enrique C. Leira. (2021) Effects of the Menstrual Cycle on Neurological Disorders. Current Neurology and Neuroscience Reports 21:7.
Crossref
Wendy Ankrom, Jialin Xu, Marie‐Helene Vallee, Marissa F. Dockendorf, Danielle Armas, Ramesh Boinpally & K. Chris Min. (2020) Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants. The Journal of Clinical Pharmacology 60:9, pages 1157-1165.
Crossref
Gabriele S. Merki-Feld. 2019. Gender and Migraine. Gender and Migraine 81 88 .
G. Robin, P. Plouvier, A.-S. Delesalle & A.-L. Rolland. (2018) Contraception hormonale en pratique hors dispositifs intra-utérins. RPC Contraception CNGOF. Gynécologie Obstétrique Fertilité & Sénologie  46:12, pages 845-857.
Crossref
Gianni Allais, Giulia Chiarle, Silvia Sinigaglia, Gisella Airola, Paola Schiapparelli & Chiara Benedetto. (2018) Estrogen, migraine, and vascular risk. Neurological Sciences 39:S1, pages 11-20.
Crossref
Samantha Warhurst, Christopher J Rofe, Bruce J Brew, Deborah Bateson, Kevin McGeechan, Gabriele S Merki-Feld, Raymond Garrick & Susan E Tomlinson. (2017) Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis. Cephalalgia 38:4, pages 754-764.
Crossref
Simona Sacco, Gabriele S. Merki-Feld, Karen Lehrmann Ægidius, Johannes Bitzer, Marianne Canonico, Tobias Kurth, Christian Lampl, Øjvind Lidegaard, E. Anne MacGregor, Antoinette MaassenVanDenBrink, Dimos-Dimitrios Mitsikostas, Rossella Elena Nappi, George Ntaios, Per Morten Sandset & Paolo Martelletti. (2017) Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). The Journal of Headache and Pain 18:1.
Crossref
Gabriele S. Merki-Feld, Gina Epple, Nina Caveng, Bruno Imthurn, Burkhardt Seifert, Peter Sandor & Andreas R. Gantenbein. (2017) Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users. The Journal of Headache and Pain 18:1.
Crossref
Taylor N. Hall & Elizabeth K. Rende. (2017) Practice Guideline: Contraception for Adolescents with Chronic Illness. Journal of Pediatric Health Care 31:3, pages 409-420.
Crossref
Gianni Allais, Giulia Chiarle, Silvia Sinigaglia, Gisella Airola, Paola Schiapparelli, Fabiola Bergandi & Chiara Benedetto. (2017) Treating migraine with contraceptives. Neurological Sciences 38:S1, pages 85-89.
Crossref
Gabriele S Merki-Feld, Bruno Imthurn, Ronald Langner, Burkhardt Seifert & Andreas R Gantenbein. (2015) Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days. The Journal of Headache and Pain 16:1.
Crossref
H. Cappy, C. Lucas, S. Catteau-Jonard & G. Robin. (2015) Migraine et contraception. Gynécologie Obstétrique & Fertilité 43:3, pages 234-241.
Crossref
Julie Craik & Louise Melvin. 2015. Medicines For Women. Medicines For Women 141 180 .
Matteo Morotti, Valentino Remorgida, Pier Luigi Venturini & Simone Ferrero. (2014) Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study. European Journal of Obstetrics & Gynecology and Reproductive Biology 183, pages 178-182.
Crossref
Sheela Mane, Saravanan Veeramalai & Meera V. V. Ragavan. (2014) Contraception for Breast Feeding Mothers with the 75 Microgram Desogestrel-Only Pill: An Indian Perspective. The Journal of Obstetrics and Gynecology of India.
Crossref
Matteo Morotti, Valentino Remorgida, Pier Luigi Venturini & Simone Ferrero. (2014) Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. European Journal of Obstetrics & Gynecology and Reproductive Biology 179, pages 63-68.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.